Immunai vs Tarsier Pharma
Immunai vs Tarsier Pharma, compared side by side on 22 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Immunai is on 69/100 and Tarsier Pharma on 47/100.
Where each one leads
Immunai
- our overall score: 69/100 against 47/100
- agent readiness: 32/100 against 21/100
- domain rating: 46/100 against 34/100
- headcount: 179 against 12
- headcount growth: +13.0% against +2.8%
- funding raised: $295M against $5.0M
- LinkedIn following: 26,832 against 1,582
Tarsier Pharma
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Immunai | Tarsier Pharma |
|---|---|---|
| What it is | Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery. | Clinical-stage company developing novel treatments for ocular inflammatory blinding diseases. |
| Category | Healthcare, Immunology, Data, Analytics | Healthcare, Disease Treatment, Vision Impairment, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Services |
| Founded | 2019 | 2016 |
| Headquarters | New York, United States | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Immunai | Tarsier Pharma |
|---|---|---|
| Employees | 179 | 12 |
| Headcount growthLast 12 months | +13.0% | +2.8% |
| Total funding | $295M | $5.0M |
| Latest round | Series B | Series B |
| Valuation | $1.0B | Not published |
| LinkedIn followers | 26,832 | 1,582 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Immunai | Tarsier Pharma |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 69/100 | 47/100 |
| Traction | 60/100 | 45/100 |
| Team | 70/100 | 20/100 |
| Search visibility | 39/100 | 31/100 |
| Quality | 78/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (32/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 46/100 | 34/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Immunai | Tarsier Pharma |
|---|---|---|
| CDN | Not detected | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Jquery, Bootstrap | Jquery |
| Analytics | Google Tag Manager | Google Analytics 4 |
Immunai vs Tarsier Pharma: common questions
Which is better, Immunai or Tarsier Pharma?
On our 0-100 score Immunai rates higher (69/100 against 47/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 22 data points above: read the rows that match what you are buying for.
How do Immunai and Tarsier Pharma compare on the numbers?
Immunai leads on our overall score (69/100 against 47/100), agent readiness (32/100 against 21/100), domain rating (46/100 against 34/100), headcount (179 against 12), headcount growth (+13.0% against +2.8%), funding raised ($295M against $5.0M), LinkedIn following (26,832 against 1,582).
Read the full Immunai review and pricing or the Tarsier Pharma review and pricing. You can also browse other Immunai alternatives we track.